Innovation Efficiency Pharmaceutical Manufacturing R & D In Investment

Since China entries into WTO, our pharmaceutical industry has maintained a sustained and rapid growth.In the past thirty years, Chinese medicine has grown faster than GDP.it has been one of the fastest growing industries in various fields of the national economy. In the economic research in the past, we can clearly see the technology is a strategic asset, for the whole economic development plays a crucial role in promoting. Technology progress is inseparable from Research and Development investment. As a knowledge-intensive industry, research of China’s pharmaceutical industry and test development activities into strength increases ceaselessly, effectively promoted the development.This paper first makes a brief introduction to the industrial organization theory, innovation theory at home and abroad as well as on the R&D input efficiency of innovation research. Through the research we can find that, although the domestic and foreign scholars for the R&D input specific how to affect the efficiency of innovation, and the importance in influencing the efficiency of technology innovation of the elements of the controversial, but there is little doubt that the R&D investment in technology innovation, the extraordinary significance, it is the important strength and promote technological progress.In third, the four chapter, I introduced the main performance of the market structure, market behavior and the pharmaceutical industry in China. The fourth chapter focuses on the characteristics of China’s R&D behavior, we can see that China’s R&D investment amount is large, but the per capita low; output, output efficiency at present in our country is not high. Sixth, seven chapters, mainly on R&D investment funds, full-time staff and absorption of imported technology digestion and equivalent funds as the input variables, the sales income of new product and patent quantity of output variables, the DEA model with variable returns to scale of China’s pharmaceutical industry R&D investment in innovation efficiency of empirical analysis, can be found, the pharmaceutical industry in our country R&D input is different for the efficiency of patent output and new product output. Through the empirical study can be found, in China’s pharmaceutical industry, with an average annual growth rate of average annual growth of patent output rate is higher than the rate of new product output value. The seventh chapter is mainly to improve the pharmaceutical industry in our country R&D innovation efficiency method is put forward according to the results of empirical analysis. To change the government function, increase R&D input, should also promote cooperation and regional cooperation.The eighth chapter is the main conclusions and prospect. At present, China’s pharmaceutical industry’s overall technological innovation efficiency is low, so this paper mainly studies the investment innovation efficiency. Impact on the pharmaceutical industry innovation efficiency factor analysis and how to realize the reasonable ratio of investment and how to accelerate the patent conversion rate will be further research in this direction.